sovhealth.com

0.0
Network
Score (What’s this?)

Perlu Network score measures the extent of a member’s network on Perlu based on their connections, Packs, and Collab activity.

We are an addiction, dual diagnosis & mental health treatment provider for adults & teens. View our patient reviews on recovery. 24/7 Helpline 866-832-0684

Share
Social Audience 20K
Categories
  • Telecommuting
  • Education
  • Family and Relationships
  • Healthy Living
  • Senior Health
  • Women's Health
  • Medical Health
  • Diseases and Conditions
  • Pharmaceutical Drugs
  • News and Politics
  • Personal Finance
Highlights
Study finds link between opioid addiction and criminal justice system

There have been reports that jails and prisons are bearing the brunt of the opioid epidemic, but we didn’t know nationally how many people who use opioids were involved in the criminal justice system,” said Winkelman.. In the wake of the opioid epidemic, experts say that it is paradoxical that prisons nationwide are mandated by law to ensure evidence-based health care for heart ailments, HIV, hypertension, diabetes, asthma, and other physical health issues, while people with opioid use disorders are generally recommended detoxification, which can be ineffective in some cases. With millions of Americans finding themselves languishing in throes of addiction, medical science experts believe that though opioids are addictive substances capable of triggering compulsive drug-seeking urges in chronic users, full-blown addiction is the result of complete emotional dependence on opioids. When wondering where to start with finding help for addiction to prescription opioids, one needn’t look further than Sovereign Health to avail the finest treatment options at our reputed prescription drug addiction treatment centers.

Open office spaces may lead to surveillance anxiety, finds study

However, a recent study conducted by the Harvard University has found that employees working in open office spaces interact more via email and less in person that goes on to hamper their productivity. The latest before-and-after study, published in the journal “Philosophical Transactions of the Royal Society B” in July 2018, was conducted by researchers Ethan Bernstein and Stephen Turban on the basis of data collected from two Fortune 500 companies. While they previously invested 5.8 hours per person a day in face-to-face interaction, this average time went down to around 1.7 hours per day. You can call at our 24/7 helpline number or chat online with our representative to get complete details about the finest anxiety disorder rehab centers, or the best rehabilitation centers in the U. S.

NPS Data Hub to facilitate faster sharing of information on new illicit drugs

In order to deal with the current situation, scientists at the National Institute of Standards and Technology (NIST) in collaboration with the U. S. Drug Enforcement Administration and the German Federal Criminal Police Office (Bundeskriminalamt) have launched a website to help forensic chemists share data on new drug variants, also known as drug analogs. Novel Psychoactive Substance (NPS) Data Hub — would allow forensic scientists to share information and useful data on analogs of new illicit drugs, including their signatures and chemical structures. The similarity in chemical structures of the two drugs make heroin a cheaper and perfect substitute for opioids, swiftly turning the opioid crisis into a heroin epidemic. When wondering where to start with to find help for addiction to drugs, one needn’t look further than Sovereign Health to avail the latest treatment options at its reputed drug addiction treatment centers.

FDA gives nod to Aristada Initio for treating schizophrenia in adults

The U. S. Food and Drug Administration (FDA) has approved Aristada Initio (aripiprazole lauroxil) to begin the development of Aristada, a long-acting injectable unusual antipsychotic, to treat schizophrenia in adults. The move will now make it possible to dose patients with Aristada Initio in combination with a single 30 mg dose of oral aripiprazole as an alternative to begin prescribing any dose of Aristada on the very first day of the treatment of the mental disorder, the manufacturer announced in a press release. This, in turn, would offer patients and health care providers a flexible treatment option as it would allow administering the first Aristada dose on the same day as Aristada Initio or up to 10 days thereafter. Dr. David Walling, chief executive officer and principal investigator of the Collaborative Neuroscience Network, said that the new Aristada Initio regimen would make it possible for patients to recover within two months of undergoing treatment while also allowing the care team to focus their efforts on other important aspects of the long-term positive outcomes.

Join Perlu And Let the Influencers Come to You!

Submit